chr22-42411442-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_145912.8(NFAM1):c.416C>T(p.Thr139Met) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.00011 in 1,613,940 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 16/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_145912.8 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
NFAM1 | NM_145912.8 | c.416C>T | p.Thr139Met | missense_variant | 2/6 | ENST00000329021.10 | NP_666017.1 | |
NFAM1 | NM_001371362.1 | c.260C>T | p.Thr87Met | missense_variant | 4/8 | NP_001358291.1 | ||
NFAM1 | NM_001318323.3 | c.416C>T | p.Thr139Met | missense_variant | 2/5 | NP_001305252.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
NFAM1 | ENST00000329021.10 | c.416C>T | p.Thr139Met | missense_variant | 2/6 | 1 | NM_145912.8 | ENSP00000333680 | P1 | |
NFAM1 | ENST00000355469.4 | n.421C>T | non_coding_transcript_exon_variant | 2/3 | 3 |
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152202Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.0000644 AC: 16AN: 248634Hom.: 0 AF XY: 0.0000817 AC XY: 11AN XY: 134588
GnomAD4 exome AF: 0.000117 AC: 171AN: 1461738Hom.: 0 Cov.: 32 AF XY: 0.000118 AC XY: 86AN XY: 727152
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152202Hom.: 0 Cov.: 32 AF XY: 0.0000538 AC XY: 4AN XY: 74346
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Sep 29, 2023 | The c.416C>T (p.T139M) alteration is located in exon 2 (coding exon 2) of the NFAM1 gene. This alteration results from a C to T substitution at nucleotide position 416, causing the threonine (T) at amino acid position 139 to be replaced by a methionine (M). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at